Clinical Trial Update: Phenelzine Sulfate and Docetaxel in Treating Patients With Prostate Cancer With Progressive Disease After First-Line Therapy With Docetaxel [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating phenelzine sulfate with docetaxel in hormone-resistant/metastatic prostate cancer after first-line docetaxel; study terminated with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hormone-resistant Prostate Cancer
• Prostate Cancer
• Prostatic Adenocarcinoma

Drugs mentioned

• DOCETAXEL (DOCETAXEL)
• Phenelzine sulfate (Phenelzine sulfate)

Snippet

Sponsor: OHSU Knight Cancer Institute | Conditions: Hormone-Resistant Prostate Cancer, Metastatic Prostatic Adenocarcinoma | Phase 2 | Status: TERMINATED | Results posted: 2017-12-11